Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Korosho to Shortly Propose Policy for Health Insurance Reform: Senior Official
September 30, 2002
- b-blockers Not Always More Effective than Ca Antagonists
September 30, 2002
- BUSINESS NEWS IN BRIEF
September 30, 2002
- COLIN Medical Instruments Receives FDA Approval for Prodigy
September 30, 2002
- NEW PRODUCTS
September 30, 2002
- Terumo Prepares CD-ROM on Proper Use of Drip Infusion Pumps
September 30, 2002
- Kyorin Revises Business Forecasts Downward
September 30, 2002
- GEYMS: New Multislice CT, LightSpeed Ultra16
September 30, 2002
- Medical Vita Japan Recruits Trial Subjects for Medical Institutions
September 30, 2002
- New Nursing Care Fees to Be Set in January
September 30, 2002
- MRs Banned to Serve as Carriers of Medical Bills: Maker FTC
September 30, 2002
- Safety Items to Be Included in Exam for Medical Professionals
September 30, 2002
- Mr Matsutani Committed to Success of IFPW Meeting in 2004 in Asia
September 30, 2002
- Pharmaceutical Education GL Presented
September 30, 2002
- Meiji Seika Expands MR Support System for Immediate PMS for Sword
September 30, 2002
- REGULATORY NEWS IN BRIEF
September 30, 2002
- Pharma Delegates Provides Opportunity to Open Communication: Chairman Brrunger
September 30, 2002
- eCTD Reaches Final ICH Step 4 at Washington Meeting
September 30, 2002
- Banyu to Boost Its Sales to \300 Bil. by FY2007: Mr Nagasaka
September 23, 2002
- Cancer Risk Increases with Level of Alcohol Consumption: Korosho Report
September 23, 2002
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…